Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

PassPort and Arcturus team up for transdermal mRNA study

EditorRachael Rajan
Published 01/05/2024, 02:07 PM
© Reuters.

SAN DIEGO - PassPort Technologies, Inc. (PPTI), a pioneer in transdermal drug delivery systems, has announced a research collaboration with Arcturus Therapeutics (NASDAQ: NASDAQ:ARCT), a leader in mRNA medicines and vaccines. This partnership aims to explore the potential of transdermal delivery for mRNA-based vaccines and therapeutics, combining PPTI's innovative PassPort® system with ARCT's mRNA and LUNAR® platform technologies.

The collaboration will focus on adapting Arcturus's select mRNA formulations for integration with the PassPort® technology, which utilizes microporation to create micropores in the skin for drug delivery. This method could offer an alternative to traditional injection and infusion methods for administering biologics and oligonucleotides.

The information in this article is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.